Progress of molecular evolution theory in research on tumorigenesi and multidrug-resistance of ovarian cancer

doi:10.3872/j.issn.1007-385X.2017.05.017

WeChat

Mobile website

2025-4-8- 19

Home
About Journal
Editorial board
Archives
Submit instruction
Invited Reviewer
Chinese

Archive > Volume 24 Issue 5 > 2017,24(5):553-557. DOI:10.3872/j.issn.1007-385X.2017.05.017 Prev Next

Review

Progress of molecular evolution theory in research on tumorigenesi and multidrug-resistance of ovarian cancer

ZHANG Liying
ZHANG Liying

Corresponding author.
Email: E-mail： zhangliying@gxmu.edu.cn
Find this author on AllJournals
Find this author on Google Scholar
Find this author on BaiDu
Find this author on PubMed
Search for this author on this site
LI Li
LI Li

Corresponding author.
Email: E-mail：lili@gxmu.edu.cn
Find this author on AllJournals
Find this author on Google Scholar
Find this author on BaiDu
Find this author on PubMed
Search for this author on this site

Article
Figures
Metrics
Preview PDF
Reference
Related
Cited by
Materials

Abstract:

Keywords:

卵巢癌 ; 分子进化 ; 多药耐药

Project Supported:

Project supported by the National Natural Science Foundation of China(No.81572579,81660430), the Scientific Research and Technology Development Program of Guangxi(No.14124004-1-24), the Natural Science Foundation of Guangxi (No.2014jjAA40637), and Self-fund Project of Guangxi Health and Family Planning Commission（No.Z2016288）

Clc Number:

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557

Article Metrics

Abstract views: 1216

PDF downloads: 1175

Html views: 0

Cited by: 0

History

Manuscript received: December 20,2016

Manuscript revised: March 08,2017

Adopted:

Online Published: June 13,2017

Published:

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557

Article Metrics

Abstract views: 1216

PDF downloads: 1175

Html views: 0

Cited by: 0

History

Manuscript received: December 20,2016

Manuscript revised: March 08,2017

Adopted:

Online Published: June 13,2017

Published:

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557

Article Metrics

Abstract views: 1216

PDF downloads: 1175

Html views: 0

Cited by: 0

History

Manuscript received: December 20,2016

Manuscript revised: March 08,2017

Adopted:

Online Published: June 13,2017

Published:

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557

Article Metrics

Abstract views: 1216

PDF downloads: 1175

Html views: 0

Cited by: 0

History

Manuscript received: December 20,2016

Manuscript revised: March 08,2017

Adopted:

Online Published: June 13,2017

Published:

More...

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557

Article Metrics

Abstract views: 1216

PDF downloads: 1175

Html views: 0

Cited by: 0

History

Manuscript received: December 20,2016

Manuscript revised: March 08,2017

Adopted:

Online Published: June 13,2017

Published:

[1]ZHANG Liying and LI Li.Progress of molecular evolution theory in research on tumorigenesi and multidrug-resistance of ovarian cancer[J].Chinses Journal of Cancer Biotherapy,2017,24(5):553-557.

[2]Yan Bingbing and Li Li.The relationship of DNA methylation with multidrug resistance and prognosis in ovarian cancer[J].Chinses Journal of Cancer Biotherapy,2015,22(3):281-289.

[3]Chen Changxian,Hu Yanling and Li Li.MicroRNA regulatory network-based prediction of multidrug resistance genes in ovarian cancer[J].Chinses Journal of Cancer Biotherapy,2015,22(2):204-208.

[4]DING Qiuhu,SHI Daohua.Research progress on molecular mechanisms of multidrug resistance in ovarian cancer[J].Chinses Journal of Cancer Biotherapy,2020,27(7):807-812.

[5]Jiang Tianmin,Wei Fang.Progress in study on drug resistance and therapy of ovarian cancer stem cell[J].Journal of Modern Oncology,2015(16):2392-2396.

[6]WANG Fen,LIU Nan-nan,SHEN Dong-lan.Development of 99mTc-MIBI scintigraphy in multidrug resistance of ovarian cancer[J].Journal of Modern Oncology,2009,17(7).

[7]王芬,刘楠楠,申东兰.Development of ^99mTC - MIBI scintigraphy in multidrug resistance of ovarian cancer[J].Shaanxi Oncology Medicine,2009,17(7):1372-1375.

[8]GAO Guo-lan,TU Kai-jia,LIU Fu-jun.Expression and reversal of multidrug resistance gene in ovarian cancer[J].Chinese Clinical Oncology,2010,15(10):870-873.

[9]Progress in the pathogenesis and molecular targeted therapy of ovarian cancer[J].Cancer Research and Clinic

[10]Ying-Jie Li,Yu-He Lei,Nan Yao,Chen-Ran Wang,Nan Hu,Wen-Cai Ye,Dong-Mei Zhang,Zhe-Sheng Chen.Autophagy and multidrug resistance in cancer[J].Chinese journal of cancer,2017,36(8).

[11]ZHANG Li,LI Jie,GUO Wei,jian.Progress in the study for mechanisms of multidrug resistance in breast cancer[J].Chinese Journal of Cancer Prevention and Treatment,2004,11(2):199-202.

[12]苏雷,魏秀芹.Progress in the study of multidrug resistance and gene therapy in lung cancer[J].Journal of International Oncology,2002,29(6):429-432.

[13]牛士贞,刘奇,李敏.Progress in the study on molecular mechanism of multidrug resistance in bone and soft tissue sarcoma[J].Journal of International Oncology,2003,30(5):398-400.

[14]SzakÁCs Gergely,Jakab Katalin,Antal Ferenc,Sarkadi Balázs.Diagnostics of multidrug resistance in cancer[J].Pathology oncology research : POR,1998,4(4):251-257.

[15]ZHANG Wei,WU Jin.The research progress on cancer multidrug resistance mechanisms[J].Journal of Practical Oncology,2015,29(4):364-367.

[16]Yang Xiao-kui,Xing Hui,Gao Qing-lei,Wang Wei,Wu Su-fang,Lu Yun-ping,Wang Shi-xuan,Ma Ding.Mdr-1 ribozyme in the reversal of multidrug resistance in human ovarian cancer[J].Chinese Journal of Oncology,2003,25(5):425-428.

[17]D R Bell,J H Gerlach,N Kartner,R N Buick,V Ling.Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance[J].Journal of clinical oncology,1985,3(3):311-315.

[18]HUANG Wen-he,LIU Dong-ju,CHEN Sheng-fa,ZHUANG Ye-zhong,WU Jun-dong.Clinical research for multidrug resistance gene expression in rectal cancer[J].Chinese Journal of Cancer Prevention and Treatment,2005,12(5):353-354.

[19]Luwei WEI,Li LI.Signaling pathways related to multidrug resistance in epithelial ovarian cancer[J].Chinese Journal of Clinical Oncology,2016,43(9):396-399.

[20]DAI Cong-wei.Paclitaxel-based multidrug combinations in advanced ovarian cancer[J].Journal of International Oncology,2006,33(6):456-459.

Get Citation

张丽滢,李力.分子进化理论在卵巢癌发生及多药耐药的研究进展[J].中国肿瘤生物治疗杂志,2017,24(5):553~557